Concepedia

Author

John F. DeBernardis

Ludwig-Maximilians-Universität München

Also Known As

J DeBernardis, J F DeBernardis, J F Debernardis, J. DEBERNARDIS, J. DeBernardis, J. F. DEBERNARDIS, J. F. DeBernardis, J. F. Debernardis, J.F. DeBernardis, John DeBernardis

89

Publications

4K

Citations

24

H-Index

64

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenAbbott FundDuke Medical CenterAbbott (United Kingdom)Duke University Hospital
JF

About

John F. DeBernardis is an author at Ludwig-Maximilians-Universität München specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

18

1.9K

2

Natural Sciences

11

11

783

3

Biochemistry

11

12

864

4

Engineering

4

4

109

5

Social Sciences

3

3

332

John F. DeBernardis

×

41

Publications

3.9K

Citations

24

H-Index

YearCitations

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Katharina Büerger, Michael Ewers, Tuula Pirttilä,

Brain

2006

584

Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease

Harald Hampel, Katharina Büerger, Raymond Zinkowski,

Archives of General Psychiatry

2004

430

Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism.

L.M. Fredrik Leeb-Lundberg, Susanna Cotecchia, Jon W. Lomasney,

Proceedings of the National Academy of Sciences

1985

331

Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231

Katharina Büerger, Raymond Zinkowski, Stefan Teipel,

Archives of Neurology

2002

276

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

Katharina Büerger, Stefan Teipel, Raymond Zinkowski,

Neurology

2002

249

MRI and CSF studies in the early diagnosis of Alzheimer's disease

Mony J. de Leon, Susan DeSanti, Raymond Zinkowski,

Journal of Internal Medicine

2004

218

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients

Russell E. Kohnken, Katharina Büerger, Raymond Zinkowski,

Neuroscience Letters

2000

177

Correlation of Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231 With Rates of Hippocampal Atrophy in Alzheimer Disease

Harald Hampel, Katharina Bürger, Jens C. Pruessner,

Archives of Neurology

2005

172

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI

Michael Ewers, Katharina Büerger, Stefan Teipel,

Neurology

2007

143

A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.

Sheila M. Knepper, S A Buckner, M.E. Brune,

Journal of Pharmacology and Experimental Therapeutics

1995

131

Page 1